跳至主要内容
临床试验/NCT05370261
NCT05370261已完成不适用

Comparing the Pharmacological Profile of Different Berberine Formulations, and Their Effects on Blood Sugar Levels

Factors Group of Nutritional Companies Inc.1 个研究点 分布在 1 个国家目标入组 12 人开始时间: 2022年2月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
12
试验地点
1
主要终点
AUC: the area under the concentration-time curve

研究概览

简要总结

The primary objective of this study is to evaluate the gastrointestinal absorption of berberine (hydrochloride) in a novel formulation in healthy adult volunteers by comparing it with free berberine (hydrochloride) formulation. Several pharmacokinetic parameters are compared.

As secondary objective, the immediate or short-term effects of Berberine supplementation on blood sugar levels in healthy volunteers are evaluated via a glucose tolerance test (OGTT) using a portable glucometer.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
21 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Age 21-65
  • •healthy, good physical condition

排除标准

  • •Pregnancy or breast-feeding
  • •Gastrointestinal conditions
  • •Acute or chronic liver disease
  • •Acute or chronic kidney disease
  • •Acute or chronic cardiovascular disease
  • •Hematological disease
  • •Allergy or Intolerance to gluten
  • •Allergy or Intolerance to Berberine
  • •Use of any form of nicotine or tobacco
  • •Alcohol and substance abuse history
  • •Use of medications (e.g., blood sugar-lowering agents, or statins)
  • •Use of Berberine supplements
  • •Participation in another investigational study

研究组 & 干预措施

Berberine LipoMicel soft-gel

Experimental

Each participant receives their treatment of Berberine LipoMicel soft-gel capsules at a total dose of 500 mg berberine. Treatments are consumed with a glass of water (approx. 200 mL), and standardized breakfast. A standardized lunch is served after the 4hr fasting; standardized dinner after 8hrs. Capillary whole blood samples are collected at time points 0, 0.5, 1, 2, 3, 4, 6, 8, 10, 12, 24 hours.

Samples that are not processed the same day are kept frozen at -20°C until further processing and analysis. Processed samples are analyzed by LC-MS within 24 hours after processing.

Participants are asked to arrive after an overnight fast (at least 9hrs). Each participant acts as their own control; there is no separate control group. A washout period of at least 7 days between each treatment will be used.

Adverse events are recorded throughout the study by direct questioning.

干预措施: Berberine LipoMicel (Dietary Supplement)

Regular Berberine hard-gel

Experimental

Each participant receives their treatment of regular Berberine hard-gel capsules at a total dose of 500 mg berberine. Treatments are consumed with a glass of water (approx. 200 mL), and standardized breakfast. A standardized lunch is served after the 4hr fasting; standardized dinner after 8hrs. Capillary whole blood samples are collected at time points 0, 0.5, 1, 2, 3, 4, 6, 8, 10, 12, 24 hours.

Samples that are not processed the same day are kept frozen at -20°C until further processing and analysis. Processed samples are analyzed by LC-MS within 24 hours after processing.

Participants are asked to arrive after an overnight fast (at least 9hrs). Each participant acts as their own control; there is no separate control group. A washout period of at least 7 days between each treatment will be used.

Adverse events are recorded throughout the study by direct questioning.

干预措施: Regular Berberine hard-gels (Dietary Supplement)

结局指标

主要结局

AUC: the area under the concentration-time curve

时间窗: 0 (baseline; pre-dose), 0.5, 1, 2, 3, 4, 6, 8, 10, 12, 24 hours (post-dose)

To evaluate the gastrointestinal absorption of orally ingested berberine (hydrochloride) in a novel formulation in healthy adult volunteers by comparing the Area under the plasma concentration versus time curve (AUC) with that of with free/regular berberine (hydrochloride).

Cmax: maximum plasma concentration

时间窗: 0 (baseline; pre-dose), 0.5, 1, 2, 3, 4, 6, 8, 10, 12, 24 hours (post-dose)

To evaluate the gastrointestinal absorption of orally ingested berberine (hydrochloride) in a novel formulation in healthy adult volunteers by comparing the Peak Plasma Concentration (Cmax) with that of with free/regular berberine (hydrochloride).

Tmax: the time point of maximum plasma concentration

时间窗: 0 (baseline; pre-dose), 0.5, 1, 2, 3, 4, 6, 8, 10, 12, 24 hours (post-dose)

To evaluate the gastrointestinal absorption of orally ingested berberine (hydrochloride) in a novel formulation in healthy adult volunteers by comparing the time point of maximum plasma concentration (Tmax) with that of with free/regular berberine (hydrochloride).

次要结局

  • Effects on Blood sugar levels(0 (Baseline; pre-dose), 0.5, 1, 2, 3, and 4 hours (post-dose))
  • Changes in Blood sugar concentrations(0 (Baseline; pre-dose), 0.5, 1, 2, 3, and 4 hours (post-dose))

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验